Category: Federal Forum Posters
Purpose: The state of Florida now requires routine utilization of the prescription drug monitoring program (PDMP) database prior to prescribing opioids. As a result, evaluating the differences in prescribing trends is crucial to determine the impact of House Bill 21: Controlled Substances (HB21). The purpose of this project is to review prescribing practices of opioids at discharge from the Bay Pines VA Healthcare System (BPVAHCS) emergency department (ED) and document any changes before and after the implementation of HB21 in Florida.
Methods: A retrospective chart review of Veterans being discharged from the ED from July 1, 2017 to September 30, 2018 will be conducted. Veterans will be included in the chart review if they were (1) treated and discharged from the ED at BPVAHCS, and (2) prescribed any opioids, including scheduled combination products (e.g., hydrocodone with acetaminophen, oxycodone with acetaminophen), in the ED for pain. Veterans undergoing inpatient hospital admission immediately after an ED visit at the BPVAHCS or previously prescribed an opioid greater than 3 months prior to their ED visit will be excluded. The medical records of each Veteran will be reviewed in order to obtain the following information: indication for opioid therapy, total number of PDMP evaluation notes, use of the term “PDMP” in an ED pharmacist or ED provider note, total number of opioids prescribed at discharge, days’ supply of opioids prescribed, time of day opioids were prescribed, and weekend or weekday visit. The results of the medication utilization review (MUE) may provide guidance for policy changes that will influence opioid prescribing practices in the ED.
Results: not applicable
Conclusion: not applicable
Clara-Jessica Rances– PGY1 Pharmacy Resident, Bay Pines VA Healthcare System, Lakeland, FL